» Authors » Yan Ting Chiang

Yan Ting Chiang

Explore the profile of Yan Ting Chiang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 152
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tam K, Dalal K, Hsing M, Cheng C, Khosravi S, Yenki P, et al.
Oncotarget . 2016 Dec; 8(6):9617-9633. PMID: 28038451
The androgen receptor (AR) is a member of the nuclear receptor superfamily of transcription factors and is central to prostate cancer (PCa) progression. Ligand-activated AR engages androgen response elements (AREs)...
2.
Clermont P, Crea F, Chiang Y, Lin D, Zhang A, Wang J, et al.
Clin Epigenetics . 2016 Feb; 8:16. PMID: 26877821
Background: While localized prostate cancer (PCa) can be effectively cured, metastatic disease inevitably progresses to a lethal state called castration-resistant prostate cancer (CRPC). Emerging evidence suggests that aberrant epigenetic repression...
3.
Hao J, Chiang Y, Gout P, Wang Y
Front Biosci (Schol Ed) . 2015 Dec; 8(1):44-55. PMID: 26709895
Recurrence of localized prostate cancer following treatment can lead to lethal metastatic castration-resistant prostate cancer. Although numerous studies aimed at developing biomarkers for predicting recurrence of localized prostate cancer are...
4.
Chiang Y, Gout P, Collins C, Wang Y
Asian J Androl . 2014 Mar; 16(4):545-8. PMID: 24589457
Metastatic prostate cancer is currently incurable. Metastasis is thought to result from changes in the expression of specific metastasis-driving genes in nonmetastatic prostate cancer tissue, leading to a cascade of...
5.
Zhang C, Kho Y, Wang Z, Chiang Y, Ng G, Shaw P, et al.
PLoS One . 2014 Jan; 9(1):e85206. PMID: 24454821
The endoplasmic reticulum (ER) is a continuous membrane network in eukaryotic cells comprising the nuclear envelope, the rough ER, and the smooth ER. The ER has multiple critical functions and...
6.
Chiang Y, Wang K, Fazli L, Qi R, Gleave M, Collins C, et al.
Oncotarget . 2014 Jan; 5(2):451-61. PMID: 24448395
Effective treatment for metastatic prostate cancer is critically needed. The present study was aimed at identifying metastasis-driving genes as potential targets for therapy (oncotargets). A differential gene expression profile of...
7.
Crea F, Sun L, Mai A, Chiang Y, Farrar W, Danesi R, et al.
Mol Cancer . 2012 Aug; 11:52. PMID: 22867098
Early prostate cancer (PCa) is generally treatable and associated with good prognosis. After a variable time, PCa evolves into a highly metastatic and treatment-refractory disease: castration-resistant PCa (CRPC). Currently, few...